Which combination drugs are classified as SABA and anticholinergic?

The combination of Albuterol and Ipratropium Bromide (often referred to by the brand name Duoneb) is classified as a SABA (Short-Acting Beta-Agonist) and anticholinergic. Albuterol is a widely used SABA that provides quick relief of asthma symptoms by relaxing the muscles in the airways, making it easier to breathe. On the other hand, Ipratropium Bromide is an anticholinergic medication that works by drying up respiratory secretions and preventing bronchoconstriction.

This dual-action approach is particularly effective for patients experiencing acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD). By combining these two classes of medication, patients benefit from enhanced bronchodilation and symptom relief.

The other options do not fit the criteria of a SABA and anticholinergic combination. Formoterol and Budesonide are both long-acting medications comprising a LABA (Long-Acting Beta Agonist) and an ICS (Inhaled Corticosteroid), respectively. Fluticasone and Salmeterol also represent a combination of an ICS and a LABA. Finally, Epinephrine and Racemic Epi are more associated with